Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
Robin Divine, MBA, president and CEO of TriCore Reference Laboratories, discusses key recent developments in the lab industry and predictions for 2024.
Healthcare leader Steve Serota discusses a new partnership and how it is bringing high-quality lab testing to underserved areas.